Last update : 03/06/2012 | Version : 1 | ID : 81
General | |
Identification | |
Detailed name | Observational study of the observance of the adjuvant treatment with Taxotere® in the operable breast cancer |
Sign or acronym | ADAGIO |
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation | Numéro CNIL = 907177, Numéro CPP = NA, Afssaps = NA |
General Aspects | |
Medical area |
Cancer research |
Others (details) | breast cancer |
Keywords | docetaxel observance in adjuvant treatment, operable breast cancer that has spread to the lymph nodes. |
Scientific investigator(s) (Contact) | |
Name of the director | VIGNAL |
Surname | Franck |
Phone | +33 (0)1 57 63 26 47 |
franck.vignal@sanofi-aventis.com | |
Unit | Sanofi Aventis |
Collaborations | |
Funding | |
Funding status |
Private |
Details | Sanofi-aventis France |
Governance of the database | |
Sponsor(s) or organisation(s) responsible | Sanofi-aventis France |
Organisation status |
Private |
Additional contact | |
Main features | |
Type of database | |
Type of database |
Study databases |
Study databases (details) |
Longitudinal study (except cohorts) |
Database recruitment is carried out by an intermediary |
A selection of health institutions and services |
Database recruitment is carried out as part of an interventional study |
No |
Database objective | |
Main objective | Evaluate the observance of the adjuvant treatment with Taxotere® in the operable breast cancer that has spread to the lymph nodes. |
Inclusion criteria |
Patients having breast cancer operated on that has spread to the lymph nodes. For whom the decision of a adjuvant chemotherapy with Taxotere® base was taken. Who have given their agreement to participate in the study. |
Population type | |
Age |
Adulthood (19 to 24 years) Adulthood (25 to 44 years) Adulthood (45 to 64 years) Elderly (65 to 79 years) Great age (80 years and more) |
Population covered |
Sick population |
Gender |
Woman |
Geography area |
National |
Detail of the geography area | Metropolitan France |
Data collection | |
Dates | |
Date of first collection (YYYY or MM/YYYY) | 2008 |
Date of last collection (YYYY or MM/YYYY) | 2010 |
Size of the database | |
Size of the database (number of individuals) |
< 500 individuals |
Details of the number of individuals | 321 |
Data | |
Database activity |
Current data collection |
Type of data collected |
Clinical data Biological data Administrative data |
Clinical data (detail) |
Direct physical measures |
Details of collected clinical data | --- |
Declarative data (detail) |
Phone interview |
Details of collected declarative data | --- |
Biological data (detail) | • Biological-hepatic balance carried out (Yes/No) and where applicable, variable(s) disturbed (transaminases, bilirubin, gamma-GT, alkaline phosphatases), |
Administrative data (detail) | • Social and occupational category, • Professional activity. • Lost work time (Yes/no) if activity. |
Presence of a biobank |
No |
Health parameters studied |
Health event/morbidity Health event/mortality |
Procedures | |
Data collection method | observance of chemo treatment, operable breast cancer |
Participant monitoring |
Yes |
Links to administrative sources |
No |
Promotion and access | |
Promotion | |
Access | |
Terms of data access (charter for data provision, format of data, availability delay) | methods for accessing the database are currently being defined |
Access to aggregated data |
Access on specific project only |
Access to individual data |
Access on specific project only |
Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05